Copyright and Licensing

Copyright and Licensing Policy

The Journal of Stem Cell Therapy and Transplantation (JSCTT) is committed to fostering the global exchange of knowledge in regenerative medicine, stem cell research, and transplantation. Our copyright and licensing policies ensure that authors retain rights over their work while enabling unrestricted dissemination of scientific advancements.

Copyright Ownership

Authors publishing in JSCTT retain full copyright ownership of their manuscripts. This allows them to:

  • Share, distribute, and archive their work freely.
  • Use their research for academic and professional purposes.
  • Include their work in repositories, conference proceedings, and grant applications.
  • Republish their content with proper acknowledgment.

By publishing in JSCTT, authors grant the journal a non-exclusive license to disseminate and archive their work for broader scientific accessibility.

Creative Commons Licensing

All articles published in JSCTT are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license permits:

  • Open access: Anyone can read and download articles without restrictions.
  • Reuse and adaptation: Research can be modified and built upon with proper attribution.
  • Global distribution: Articles can be freely shared across platforms.
  • No additional restrictions: The work remains fully accessible for educational and research purposes.

This licensing model fosters collaboration in the field of stem cell therapy, regenerative medicine, and transplantation science.

Author Rights and Publication Ethics

JSCTT adheres to ethical publishing standards established by the Committee on Publication Ethics (COPE). Authors are expected to:

  • Ensure originality and avoid plagiarism.
  • Properly acknowledge contributions from co-authors and institutions.
  • Disclose conflicts of interest to maintain research integrity.
  • Follow ethical guidelines for data collection, human subjects, and laboratory research.

Instances of copyright infringement, plagiarism, or ethical violations will result in manuscript rejection or retraction.

Reproduction and Usage Guidelines

JSCTT articles can be used under the following conditions:

  • Proper citation: The original authors and journal must be credited.
  • Educational use: Articles may be used for teaching, training, and academic discussions.
  • Non-commercial purposes: Commercial usage requires explicit permission.
  • Preservation of scientific integrity: The meaning and conclusions of the work must not be altered.

For permissions related to commercial use, translations, or adaptations, authors should contact the editorial office.

Copyright Disputes and Violations

JSCTT strictly enforces copyright policies. Any disputes or claims regarding copyright infringement should be reported to the editorial team with supporting documentation. Violations may lead to legal action and content retraction.

For copyright concerns, contact: [email protected]

Advancing Stem Cell Research and Regenerative Medicine

By publishing in JSCTT, authors contribute to an open-access platform that accelerates advancements in regenerative medicine, tissue engineering, and cell-based therapies. Our ethical and transparent publishing policies ensure that vital discoveries remain accessible to researchers, clinicians, and the global scientific community.

Together, we drive innovation in stem cell research for better healthcare and patient outcomes!

For further details, visit our journal website or contact our editorial office at [email protected].